AI chatbots may assist in mental health, but they cannot replace the essential human connection provided by psychiatrists and therapists.

Alto Neuroscience pioneers drug development for cognitive impairment in schizophrenia, targeting biomarkers to enhance treatment precision and patient outcomes.

Psychiatrists advocate for mental health rights amid political turmoil, urging reconsideration of harmful health policies affecting vulnerable populations.

Onfasprodil shows promise as a rapid treatment for resistant depression, offering fewer side effects than ketamine in recent clinical trials.

Explore the intersection of psychiatry and the US Constitution, examining progress and ongoing challenges in mental health and societal well-being.

Half of patients with stuttering also experience anxiety, highlighting the psychiatrist’s role in care and support.

FDA clears accelerated deep TMS protocol for major depressive disorder, offering faster treatment with similar outcomes and fewer visits.

Combining cognitive behavioral therapy with medication enhances ADHD treatment in adults, showing significant benefits within 3 months.

Because stuttering represents a spectrum disorder, a spectrum of treatments are needed.

Adial Pharmaceuticals has received feedback from FDA on the AD04 phase 3 adaptive clinical trial design and broader clinical development strategy.

Peer mentoring enhances psychiatric care by supporting new providers, reducing burnout, and fostering collaboration among NPs and PAs in mental health.

Timing hormone replacement therapy post-menopause significantly influences Alzheimer disease risk, with early treatment offering protective benefits against cognitive decline.

What is the role of GLP-1 agonists in psychiatry? Joseph F. Goldberg, MD, and Roger S. McIntyre, MD, FRCPC, share their thoughts.

Chatbots engage youth with connection but pose serious risks, potentially harming mental health and fostering unhealthy attachments. Awareness and regulation are crucial.

"What they taught in school was not what we needed, and what we needed (they said) could not be conveyed."

Explore the impact of moral injuries on health care workers and the need for systemic change to support their well-being and mental health.

Discover effective strategies to build resilience and thrive through life's challenges, from personal growth to support systems and professional help.

New research highlights the effectiveness of early psychosis intervention programs, emphasizing low caseloads and clozapine access to reduce relapse rates.

Explore the evolving landscape of moral injury treatment in health care, emphasizing trust, advocacy, and innovative therapeutic approaches.

America is in the world, the world is in America.

Shelly Jo Kraft, MS, PhD, lays the foundation for a new approach that emphasizes the role of comorbidities in stuttering.

Shahriar SheikhBahaei, PhD, discusses how animal models may lead to better treatments.

Collaborating with speech pathologists and others improve care for patients who stutter.

Shahriar SheikhBahaei, PhD, shares insights into the neurobiology of stuttering at STARS conference.